Advertisement Eurand names new chief medical officer - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Eurand names new chief medical officer

Eurand, a specialty pharmaceutical company, has appointed Ruth Thieroff-Ekerdt to the newly created position of chief medical officer, effective December 1, 2008. She will be based in the company's Yardley, Pennsylvania, office.

Dr Thieroff-Ekerdt will have full responsibility for managing Eurand’s clinical R&D, medical and regulatory affairs, and drug safety and surveillance activities.

Before joining Eurand, Dr Thieroff-Ekerdt was vice president of global clinical and medical affairs for Bayer Consumer Care, with responsibility for clinical development, clinical operations, medical affairs and pharmacovigilance for consumer care products worldwide. Her experience also includes positions of increasing scope and responsibility at the Berlex division of Schering.

Gearoid Faherty, chairman and CEO of Eurand, said: “We look forward to benefiting from her expertise, leadership skills and wide range of experience in all phases of drug development.”